Welcome

Ancora is a biopharmaceutical company developing novel immune modulation therapeutics and vaccines using synthetic carbohydrates. Ancora’s technology platform is enabling unique opportunities by accelerating each facet of carbohydrate therapeutic discovery. A key capability provided by this proprietary platform is the ability to generate significant quantities of homogeneous, complex carbohydrates through chemical synthesis rather than traditional enzymatic synthesis or purification from biological sources. A chemical synthesis approach to carbohydrates provides several advantages to drug discovery and development.

Ancora’s initial focus is the development of synthetic carbohydrate-based vaccines to combat bacterial, parasitic and viral infectious diseases. Ancora also is evaluating synthetic carbohydrate molecules in a strategic array of immune modulation applications, establishing a robust product portfolio.